Valeant Pharmaceuticals is acquiring Afexa Life Sciences for C$0.85 per share, or about $85.7 million (C$87.7 million)

Afexa Life Sciences Inc.

Canada / Other

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Valeant Pharmaceuticals International Inc.

Canada / Mid-Cap Biopharma ($1-$50 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed